Faisal Ghiath Sukhtian serves as Executive at Outlook Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Faisal Ghiath Sukhtian has executed 5 insider transactions totaling $88.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 7, 2022 involved purchasing 30,000 shares valued at $38.7K.
Faisal Ghiath Sukhtian currently holds 68,000 shares of Outlook Therapeutics, Inc. (OTLK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Faisal Ghiath Sukhtian has been a net buyer of OTLK stock. They have purchased $88.8K and sold $0 worth of shares.
Faisal Ghiath Sukhtian's most recent insider trade was on Oct 7, 2022, when they purchased 30,000 shares at $1.29 per share.
Get notified when new Form 4 filings are submitted
| $1.40 |
| Discretionary |
| Apr 19, 2021 | OTLK | $18.2K | Purchase | 10,000 | $1.82 | Discretionary |
| Sep 17, 2020 | OTLK | $6.7K | Purchase | 10,000 | $0.67 | Discretionary |
| Feb 1, 2019 | OTLK | $4.0M | Award | 4,288,624 | $0.93 | Discretionary |